Dehydrocostus lactone attenuates hepatic steatosis by regulating fatty acid oxidation and lipid metabolism: integrated transcriptomic and metabolomic analysis
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-07 · 399 (10) · 15351-15362
DOI: 10.1007/s00210-026-05388-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 27.04.2026. Verfasst von Xiaojia Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangdong Medical University, Dongguan, 523808, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Lactones, Fatty Acids, Sesquiterpenes. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation of China.
Abstract (Originalsprache)
Metabolic dysfunction-associated fatty liver disease (MAFLD) and atherosclerosis (AS) are closely linked cardiometabolic disorders characterized by dysregulated lipid metabolism, inflammation, and insulin resistance. This study investigated the effects of dehydrocostus lactone (DHL) on hepatic lipid metabolism and histopathology in a preclinical mouse model of concurrent MAFLD and AS, and elucidated its underlying molecular mechanisms. Apolipoprotein E-deficient (ApoE-/-) mice were fed a high-fat diet (HFD) for 10 weeks and treated with low, medium, or high doses of DHL, or simvastatin as a positive control. Liver morphology, histology (H&E, Masson's trichrome, Oil Red O staining), and biochemical markers of total cholesterol (TC), triglyceride (TG), Aspartate aminotransferase, Alanine aminotransferase were assessed. Integrated transcriptomic and metabolomic analyses of liver tissues were performed to identify DHL-regulated signaling pathways. DHL markedly reduced hepatic lipid accumulation and collagen deposition compared with HFD controls, as evidenced by decreased Oil Red O-positive areas and reduced TC and TG levels. DHL improved liver fibrosis and normalized serum transaminases without significantly affecting body weight. Mechanistically, DHL upregulated peroxisome proliferator-activated receptor alpha (PPAR-α) and its downstream target carnitine palmitoyl-transferase 1β (CPT1-β), enhancing fatty acid β-oxidation, while suppressing fatty acid binding protein 5 (FABP5) to reduce intracellular lipid retention. Metabolomic profiling revealed restoration of carnitine pools and vitamin A levels, indicating improved mitochondrial fatty acid transport and hepatic function. DHL exerts multi-targeted protective effects against HFD-induced hepatic steatosis in ApoE-/- mice by coordinately regulating lipid oxidation, uptake, and metabolic pathways, which suggests that DHL represents a promising therapeutic candidate for the concurrent management of MAFLD and AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Guangdong Medical University, Dongguan, 523808, China.
- Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
- School of Medical Technology, Guangdong Medical University, Dongguan, 523808, China.
- Clinic of Guangdong Medical University, Dongguan, 523808, China. 1015056081@qq.com.
- School of Basic Medical Sciences, Guangdong Medical University, Dongguan, 523808, China. zzzhang@gdmu.edu.cn.
Förderung
- Guangdong Basic and Applied Basic Research Foundation of China
Zitieren
APA
Chen, X., Zhang, P., Liang, H., Xiao, J., Hong, W., Chen, G., Chen, R., & Zhang, Z. (2026). Dehydrocostus lactone attenuates hepatic steatosis by regulating fatty acid oxidation and lipid metabolism: integrated transcriptomic and metabolomic analysis. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(10), 15351-15362. https://doi.org/10.1007/s00210-026-05388-5
Vancouver
Chen X, Zhang P, Liang H, Xiao J, Hong W, Chen G, et al. Dehydrocostus lactone attenuates hepatic steatosis by regulating fatty acid oxidation and lipid metabolism: integrated transcriptomic and metabolomic analysis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(10):15351-15362. doi:10.1007/s00210-026-05388-5
BibTeX
@article{Chen2026,
author = {Chen, Xiaojia and Zhang, Pengfei and Liang, Haolin and Xiao, Jiahai and Hong, Weitao and Chen, Gengji and Chen, Ruhong and Zhang, Zhizhen},
title = {Dehydrocostus lactone attenuates hepatic steatosis by regulating fatty acid oxidation and lipid metabolism: integrated transcriptomic and metabolomic analysis},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {10},
pages = {15351--15362},
doi = {10.1007/s00210-026-05388-5}
}
EUVIMED